FDA Approves First Intravenous Formulation of Acetaminophen
Finally US FDA approves the first and only preparation containing acetaminophen that can be used intravenously.
Manufacturer:Cadence Pharmaceuticals, Inc
- mild to moderate pain,
- moderate to severe pain with adjunctive opioid analgesics,
- reduction of fever.
Special Consideration & Guidelines:
Ofirmev is to be administered only as a 15-minute infusion. Max daily dose should not exceed 4g.
Caution is advised when treating patients with hepatic impairment or active liver disease, alcoholism, chronic malnutrition, severe hypovolemia, or severe renal impairment.